Daré Bioscience, Inc.

NasdaqCM:DARE Stock Report

Market Cap: US$12.5m

Daré Bioscience Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of DARE?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders138,5480.906%
Private Companies1,109,4287.26%
Institutions1,309,5258.56%
General Public12,732,00183.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16%.

Top Shareholders

Top 25 shareholders own 16.71% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.26%
Law Custodial Inc.
1,109,428US$909.6k0%no data
4.79%
Vanguard Capital Management, LLC
732,146US$600.3k38.6%no data
0.92%
Geode Capital Management, LLC
140,093US$114.9k-21.2%no data
0.79%
U.S. Bancorp Asset Management, Inc.
120,920US$99.1k32.3%no data
0.52%
Sabrina Johnson
80,173US$65.7k0%no data
0.42%
BlackRock, Inc.
64,248US$52.7k279%no data
0.31%
State Street Investment Management
47,415US$38.9k102%no data
0.24%
Lisa Walters-Hoffert
36,959US$30.3k0%no data
0.24%
Jane Street Group, LLC
36,092US$29.6k0%no data
0.22%
Northern Trust Global Investments
34,209US$28.0k122%no data
0.15%
Hudson River Trading LLC
22,430US$18.4k0%no data
0.13%
Robin Steele
20,515US$16.8k0%no data
0.1%
Virtu Financial, Inc.
15,803US$13.0k0%no data
0.097%
LPL Financial LLC
14,889US$12.2k1.71%no data
0.097%
Raymond James Financial, Inc.
14,864US$12.2k-3.07%no data
0.087%
T. Rowe Price Group, Inc.
13,318US$10.9k30.3%no data
0.073%
Sterne Agee Asset Management, Inc.
11,153US$9.1k0%no data
0.071%
Objectivity Squared, LLC
10,915US$8.9k0%no data
0.062%
Farther Finance Advisors, LLC
9,450US$7.7k1.34%no data
0.05%
FMR LLC
7,571US$6.2k0.01%no data
0.045%
UBS Asset Management AG
6,810US$5.6k-84.3%no data
0.019%
Vanguard Global Advisers, LLC
2,940US$2.4k0%no data
0.0089%
Bay Harbor Wealth Management, LLC
1,358US$1.1k0%no data
0.0062%
IFS Advisors, LLC
950US$778.50%no data
0.0056%
William Rastetter
859US$704.50%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/23 02:57
End of Day Share Price 2026/08/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Daré Bioscience, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Brian Kemp DolliverBrookline Capital Markets
Douglas TsaoH.C. Wainwright & Co.
Jason McCarthyMaxim Group